SCHEMBL4796474

SCHEMBL4796474

CCOC(=O)C1CC2CCCCC2N1C(=O)OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE P12821 6/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
LMNA P02545 2/20 0.51
USP2 O75604 1/20 0.51
CYP3A4 P08684 1/20 0.48
ALOX15 P16050 1/20 0.48
HTR2C P28335 1/20 0.47
POLB P06746 1/20 0.46
FKBP1A P62942 3/20 0.46
PKM P14618 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HSD17B10 Q99714 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TSHR P16473 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4797492 0.91 HTR2C (0.46) ACEMEN1KMT2ALMNAUSP2
SCHEMBL9877388 0.91 FKBP1A (0.49) ACEMEN1KMT2ACYP3A4ALOX15
SCHEMBL9878033 0.91 FKBP1A (0.49) ACEMEN1KMT2ACYP3A4ALOX15
SCHEMBL4798767 0.90 FKBP1A (0.49) ACEMEN1KMT2ALMNAUSP2
SCHEMBL26397760 0.90 HTR2C (0.50) MEN1KMT2AHTR2CPOLBFKBP1A
SCHEMBL28453965 0.90 HTR2C (0.50) MEN1KMT2AHTR2CPOLBFKBP1A
SCHEMBL4802081 0.89 CYP3A4 (0.46) ACEMEN1KMT2ALMNAUSP2
SCHEMBL4800443 0.88 ACE (0.46) ACEMEN1KMT2ALMNAUSP2
SCHEMBL4799220 0.88 CYP3A4 (0.44) ACEMEN1KMT2ALMNAUSP2
SCHEMBL4798899 0.88 ACE (0.48) ACEMEN1KMT2ALMNAUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7439036-B2 Process for producing optically active octahydro-1H-indole-2-carboxylic acid SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-10-21 US disclosed
EP-1536017-B1 Process for producing optically active octahydro-1H-indole-2-carboxylic acid SUMITOMO CHEMICAL CO (JP) 2007-04-18 EP disclosed
EP-1536017-A2 Process for producing optically active octahydro-1H-indole-2-carboxylic acid Sumitomo Chemical Company, Limited (JP) 2005-06-01 EP disclosed
US-20050106690-A1 Process for producing optically active octahydro-1H-indole-2-carboxylic acid SUMITOMO CHEMICAL COMPANY, LIMITED 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050106690-A1 Process for producing optically active octahydro-1H-indole-2-carboxylic acid IDO1, IDO2, APEH ACE 1148/4885MEN1 1912/4885KMT2A 1707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.